Russia's Fastest CRO and clinical trials in Russia - Synergy Research Group (Synergy). - Home

+++MAY 2018: NEW CRA III HIRED IN KIEV, NEW CRA I AND CRA II IN MOSCOW+++A NEW BE STUDY STARTED+++RUSSIAN MOH APPROVED OUR NEW NIS STUDY IN PATIENTS WITH AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS+++ THE FIRST PATIENT IS RANDOMIZED INTO PHASE III STUDY IN PATIENTS WITH MULTIPLE SCLEROSIS+++ APRIL 2018: SYNERGY TOOK PART IN THE INTERNATIONAL EXHIBITION OF PHARMACEUTICALS, ENGINEERING AND BIOTECHNOLOGY IPHEB RUSSIA 11–13 APRIL 2018 IN SAINT-PETERSBURG. DURING IPHEB RUSSIA EDUCATIONAL PROGRAMME OUR SPEAKER EVGENY POLTANOV SHARED HIS EXPERIENCE IN PEOPLE MANAGEMENT IN CLINICAL TRIALS+++ NEW CRA II HIRED IN YEKATERINBURG+++MARCH 2018: NEW CTAS HIRED IN MOSCOW AND KIEV, NEW CRA I IN NOVOSIBIRSK+++UKRAINIAN MOH APPROVED OUR NEW PHASE III STUDY IN PATIENTS SUFFERING FROM AMYOTROPHIC LATERAL SCLEROSIS (ALS)+++THE FIRST PATIENTS ARE RANDOMIZED INTO PHASE III STUDY IN ADULTS WITH NASAL CONGESTION CAUSED BY ACUTE UPPER RESPIRATORY TRACT INFECTION+++FIRST SITE WAS INITIATED IN PHASE I STUDY IN HEALTHY VOLUNTEERS+++FIRST SITE WAS INITIATED IN PHASE III STUDY TO COMPARE SOLUTIONS USED FOR PRESERVATION OF THE TRANSPLANTED ORGANS+++FEBRUARY 2018: THE FIRST PATIENT IS RANDOMIZED INTO PHASE III STUDY IN ELDERLY PATIENTS TO PREVENT COGNITIVE DISORDERS AFTER EXTENSIVE SURGICAL OPERATIONS+++FIRST SITE WAS INITIATED IN PHASE III STUDY IN ADULTS WITH NASAL CONGESTION CAUSED BY ACUTE UPPER RESPIRATORY TRACT INFECTION+++THE LAST PATIENT WAS RANDOMIZED INTO PHASE III STUDY IN PATIENTS WITH IDIOPATHIC MENORRHAGIA+++ JANUARY 2018:A NEW PHASE III STUDY STARTED IN CANADA IN PATIENTS SUFFERING FROM AMYOTROPHIC LATERAL SCLEROSIS (ALS)+++ NEW CTAs HIRED IN MOSCOW AND SAINT-PETERSBURG!+++ DECEMBER 2017: THE LAST PATIENT WAS RANDOMIZED INTO PHASE III STUDY IN PATIENTS WITH FACIAL ACNE VULGARIS+++ NEW CHIEF STRATEGY OFFICER APPOINTED+++CLINICAL DATABASE WAS LOCKED FOR OUR BE STUDY+++NOVEMBER 2017: THE LAST PATIENT WAS RANDOMIZED INTO PHASE II STUDY IN PATIENTS WITH HER2 NEGATIVE, ER POSITIVE METASTATIC BREAST CANCER+++ OCTOBER 2017: THE FIRST PATIENT IS RANDOMIZED INTO PHASE III STUDY IN PATIENTS WITH VASOMOTOR SYMPTOMS +++ NEW BE STUDY STARTED +++ SEPTEMBER 2017: NEW PHASE III STUDY IN PATIENTS WITH FACIAL ACNE VULGARIS STARTED IN GEORGIA AND UKRAINE +++ JULY 2017: NEW PHASE III STUDY IN ELDERLY PATIENTS WITH COGNITIVE DYSFUNCTION AFTER MINOR SURGERY STARTED IN RUSSIA +++ JUNE 2017: THE FIRST PATIENT IS RANDOMIZED IN UKRAINE IN A PHASE III STUDY IN PATIENTS WITH FACIAL ACNE VULGARIS +++ MAY 2017: A NEW STUDY IN PATIENTS WITH NASAL CONGESTION CAUSED BY AN ACUTE UPPER RESPIRATORY TRACT INFECTION STARTED +++ THE FIRST PATIENT IS RANDOMIZED INTO PHASE III STUDY IN PATIENTS WITH FACIAL ACNE VULGARIS +++ 300 PATIENTS ARE RANDOMIZED IN TIME IN PHASE III STUDY IN PATIENTS WITH OVERACTIVE BLADDER +++ APRIL 2017: THREE NEW STUDIES STARTED IN RUSSIA, UKRAINE AND LITHUANIA +++ MARCH 2017: THE FIRST PATIENT IS RANDOMIZED INTO PHASE 2-3 STUDY IN PATIENTS WITH METASTATIC COLORECTAL CANCER +++ THE FIRST PATIENT IS RECRUITED IN A STUDYEFFICACY AND SAFETY OF THE BIOSIMILAR IN COMPARISON TO THE ORIGINAL IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION +++ DECEMBER 2016: THE FIRST PATIENT IS SCREENED IN UKRAINE IN PHASE III STUDY IN PATIENTS WITH ASTHMA UNCONTROLLED WITH HIGH DOSE OF INHALED CORTICOSTEROIDS +++ TWO NEW BE STUDIES WERE STARTED IN DECEMBER +++ NEW PHASE III STUDY IN PATIENTS WITH FACIAL ACNE VULGARIS IS STARTED IN UKRAINE AND GEORGIA +++

About Us CRO Services Expertise Analytics Why Synergy Contact
[ About Us ] [ CRO Services ] [ Expertise ] [ Analytics ] [ Why?.. ]   [ Contact ]